Insider: Watanabe Todd See Remarks - Arcutis Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 891,440 | 0 | 891,440 |
| Value | $15,644,772.00 | $0.00 | $15,644,772.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/09/2025 | DDS | 504 | Direct | COM | $17.52 | $8,829.02 | 891,440 |
| 09/08/2025 | DDS | 9,625 | Direct | COM | $17.54 | $168,799.40 | 891,944 |
| 08/04/2025 | DDS | 11,547 | Direct | COM | $14.33 | $165,429.25 | 901,569 |
| 05/02/2025 | DDS | 11,448 | Direct | COM | $15.19 | $173,916.87 | 913,795 |
| 03/25/2025 | DDS | 2,171 | Direct | COM | $17.56 | $38,131.44 | 925,243 |
| 03/24/2025 | DDS | 1,500 | Direct | COM | $17.52 | $26,281.95 | 927,414 |
| 03/17/2025 | DDS | 1,200 | Direct | COM | $17.61 | $21,137.04 | 928,914 |
| 03/04/2025 | DDS | 4,135 | Direct | COM | $13.28 | $54,929.75 | 930,114 |
| 03/03/2025 | DDS | 20,880 | Direct | COM | $13.03 | $272,089.37 | 934,249 |
| 02/03/2025 | DDS | 19,301 | Direct | COM | $12.70 | $245,122.70 | 804,129 |
| 12/20/2024 | DDS | 15,000 | Direct | COM | $15.17 | $227,566.50 | 823,430 |
| 11/30/2024 | AAP | 2,038 | Direct | COM | $7.11 | $14,482.03 | 838,430 |
| 11/04/2024 | DDS | 13,871 | Direct | COM | $8.68 | $120,458.54 | 832,392 |
| 08/02/2024 | DDS | 14,487 | Direct | COM | $9.02 | $130,648.11 | 846,263 |
| 05/31/2024 | AAP | 4,000 | Direct | COM | $1.69 | $6,768.00 | 836,392 |
| 05/02/2024 | DDS | 13,783 | Direct | COM | $8.74 | $120,433.10 | 860,750 |
| 03/04/2024 | DDS | 14,903 | Direct | COM | $11.12 | $165,739.24 | 874,533 |
| 02/28/2024 | DDS | 2,465 | Direct | COM | $10.60 | $26,129.00 | 889,436 |
| 05/31/2023 | AAP | 1,463 | Direct | COM | $6.38 | $9,333.94 | 515,145 |
| 03/06/2023 | DDS | 2,435 | Direct | COM | $15.26 | $37,167.35 | 366,657 |
| 03/02/2023 | DDS | 69 | Direct | COM | $16.52 | $1,139.88 | 369,092 |
| 03/02/2023 | DDS | 5,403 | Direct | COM | $15.82 | $85,465.73 | 369,161 |
| 02/28/2023 | DDS | 2,343 | Direct | COM | $16.17 | $37,877.64 | 374,564 |
| 02/14/2023 | DDS | 417 | Direct | COM | $17.02 | $7,097.34 | 377,007 |
| 02/14/2023 | DDS | 100 | Direct | COM | $17.03 | $1,703.00 | 376,907 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research